SeaCrest Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-11,036
Closed -$348K – 678
2022
Q2
$348K Buy
11,036
+6,208
+129% +$217K 0.04% 433
2022
Q1
$222K Buy
4,828
+505
+12% +$24.1K 0.03% 621
2021
Q4
$265K Sell
4,323
-238
-5% -$16.5K 0.03% 552
2021
Q3
$341K Buy
4,561
+2,041
+81% +$171K 0.04% 461
2021
Q2
$233K Sell
2,520
-4,763
-65% -$405K 0.03% 585
2021
Q1
$646K Buy
7,283
+1,018
+16% +$101K 0.09% 252
2020
Q4
$584K Sell
6,265
-754
-11% -$60.1K 0.08% 256
2020
Q3
$447K Sell
7,019
-1,355
-16% -$79.4K 0.07% 272
2020
Q2
$437K Sell
8,374
-7,948
-49% -$341K 0.08% 276
2020
Q1
$511K Sell
16,322
-2,608
-14% -$87.1K 0.11% 204
2019
Q4
$635K Sell
18,930
-6,118
-24% -$194K 0.11% 226
2019
Q3
$739K Sell
25,048
-8,958
-26% -$291K 0.14% 189
2019
Q2
$1.17M Buy
34,006
+16,678
+96% +$535K 0.24% 96
2019
Q1
$570K Sell
17,328
-2,380
-12% -$70.3K 0.1% 207
2018
Q4
$473K Sell
19,708
-7,433
-27% -$209K 0.1% 215
2018
Q3
$907K Buy
27,141
+5,054
+23% +$160K 0.15% 135
2018
Q2
$642K Buy
+22,087
New +$615K 0.12% 187

Other funds holding ARKG

SeaCrest Wealth Management's ARKG Position: Q3 2022 in Review

SeaCrest Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2022, closing a stake of 11,036 shares — an estimated $348K sold.

SeaCrest Wealth Management first reported a position in ARKG in Q2 2018 and held it in 17 quarters. The position peaked at $1.17M in Q2 2019. 312 funds tracked by Wall St. Rank hold ARKG as of Q3 2022.

  • SeaCrest Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q3 2022 after selling out during the quarter.
  • SeaCrest Wealth Management sold 11,036 ARK Genomic Revolution ETF shares in Q3 2022, an estimated $348K.
  • SeaCrest Wealth Management first reported a position in ARK Genomic Revolution ETF in Q2 2018 and held it in 17 quarters.
  • SeaCrest Wealth Management's ARK Genomic Revolution ETF position peaked at $1.17M in Q2 2019.
  • 312 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2022.

Based on SeaCrest Wealth Management's 13F filing for Q3 2022, filed 15 Nov 2022.